Cargando…
DNA damage is overcome by TRIP13 overexpression during cisplatin nephrotoxicity
Cisplatin is a commonly used chemotherapeutic agent to treat a wide array of cancers that is frequently associated with toxic injury to the kidney due to oxidative DNA damage and perturbations in cell cycle progression leading to cell death. In this study, we investigated whether thyroid receptor in...
Autores principales: | Hama, Taketsugu, Nagesh, Prashanth K.B., Chowdhury, Pallabita, Moore, Bob M., Yallapu, Murali M., Regner, Kevin R., Park, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663775/ https://www.ncbi.nlm.nih.gov/pubmed/34806647 http://dx.doi.org/10.1172/jci.insight.139092 |
Ejemplares similares
-
TRIP13-deficient tubular epithelial cells are susceptible to apoptosis following acute kidney injury
por: Pressly, Jeffrey D., et al.
Publicado: (2017) -
Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer
por: Chowdhury, Pallabita, et al.
Publicado: (2018) -
Indocyanine Green-based Glow Nanoparticles Probe for Cancer Imaging
por: Chauhan, Neeraj, et al.
Publicado: (2023) -
Tannic Acid Induces Endoplasmic Reticulum Stress-Mediated Apoptosis in Prostate Cancer
por: Nagesh, Prashanth K.B., et al.
Publicado: (2018) -
Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages
por: Gong, Yuqing, et al.
Publicado: (2020)